Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis – A Systematic Literature Review
| Autor: | Christopher M. Black, Johan Dalén, Axel Svedbom, Mary Dozier, Amy Puenpatom, Karin Luttropp |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
business.industry Health Policy Inflammatory arthritis 05 social sciences MEDLINE Medicine (miscellaneous) Arthritis Biologic treatment medicine.disease Ulcerative colitis 0506 political science Discontinuation 03 medical and health sciences 0302 clinical medicine Systematic review Patient experience 050602 political science & public administration medicine 030212 general & internal medicine Intensive care medicine business Pharmacology Toxicology and Pharmaceutics (miscellaneous) Social Sciences (miscellaneous) |
| Zdroj: | Patient Preference and Adherence. 14:309-320 |
| ISSN: | 1177-889X |
| Popis: | Purpose To obtain an up-to-date overview of the measurement of patient experience of switching biologic treatment in patients with inflammatory arthritis (IA) or ulcerative colitis (UC). Secondary objectives included summarizing the types of patient-reported outcomes (PROs) used (if any), and related findings; and summarizing medical and non-medical reasons for treatment switch and/or discontinuation. Methods A systematic literature review (SLR) was performed, searching Medline and Embase for relevant publications. Results In total, 70 relevant publications were identified. While the majority of these reported reasons for switching and/or discontinuing treatment, only four provided information explicitly regarding patient-reported experience of switching biologic treatment. All four utilized ranking tools to assess patient experience of switching biologic treatment. The most common reason for switching and/or discontinuing treatment was loss of efficacy, while the least common reason was patient preference. Conclusion Although the number of available treatments in IA and UC have increased, there is a sparsity of information regarding patient-reported experience of switching biologic treatment. Further research regarding patient preference and/or experience would benefit this therapeutic area and help guide treatment choices. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |